IP Infusion to Release ZebOS(R) Network Platform 7.8

SUNNYVALE, Calif., Feb. 2 /PRNewswire/ -- IP Infusion, an ACCESS company and provider of intelligent software for Next Generation Network (NGN) equipment manufacturers and converged IP services providers, today announced the release of its ZebOS® Network Platform version 7.8 software. Available in April 2010, ZebOS® 7.8 features support for Generalized Multiprotocol Label Switching (GMPLS), Data Center Bridging, Multi-Protocol Label Switching (MPLS) resiliency for wireless backhaul and Metro Ethernet Forum (MEF) implementations required for Carrier Ethernet deployments.

GMPLS Support

Today's networks are long overdue for a major upgrade to next generation packet-based optical technology. Moving forward, NGN technology will need automated interface-independent provisioning, simplified network administration and IP/MPLS enabled end-to-end networks. GMPLS has been standardized to add control plane functionality that was missing in MPLS and will deliver a seamless control plane and network management at the performance and price-points required by equipment manufacturers today. ZebOS 7.8 is the first solution to embrace GMPLS support features, and subsequent releases of the ZebOS Network Platform will continue to enhance this support.

"Driven by the explosive growth in today's mobile devices, demand for network traffic bandwidth and capacity is doubling every year, and is now overwhelming the legacy SONET based networks," said Koichi Narasaki, president and CEO, IP Infusion. "The new, ground-breaking features included in ZebOS 7.8 will change the way network equipment manufacturers design networks, thus solidifying IP Infusion's role as an industry leader in providing the essential, market-ready solutions vendors need to rapidly deploy products in the expanding NGN markets."

Data Center Bridging

Many data centers have multiple technologies that result in redundant equipment and non-optimized management, leading to high operational and plant costs. As bandwidth and capacity needs are expanding the size of traditional data centers, change is in progress that will optimize these data centers for power, area, management and costs. Data Center Bridging is a unifying Ethernet-based technology for switch fabrics in the data center. ZebOS 7.8 will include Ethernet-based Data Center Bridging to enable the implementation of converged single technology switch fabrics in the data center, aimed at optimizing traffic and reducing costs, power and space requirements.

Wireless Access/Backhaul

Demand for bandwidth from mobile and mobile Web-based devices, as well as broadband access, is requiring that backhaul networks be all-Ethernet/IP. ZebOS 7.8 enhances Carrier Ethernet and MPLS solutions to support the latest features and reliability requirements for wireless backhaul.  ZebOS 7.8 enhances MPLS reliability features such as Virtual Circuit Connectivity Verification (VCCV), Bi-Directional Forwarding Detection (BFD) for MPLS LSPs, and BFD for VCCV.

In addition to maintaining the features of ZebOS 7.7, ZebOS 7.8 also includes:

• MEF specifications (MEF-2,9,11,16,13,17,19,20)
• BGP Multipath Routing
• Policy Based Routing

IP Infusion specializes in helping equipment providers bring IP/Ethernet based NGN equipment to market on time, with assured quality and reduced cost and risk. The ZebOS Network Platform utilizes a scalable, modular architecture for routing and switching software. ZebOS provides customers in the service provider, enterprise networks and data center markets with robust, standards-based solutions. When combined with IP Infusion's Network Solutions Services, including product definition, design, architecture, development and testing, ZebOS delivers a complete, fully customized solution to market.

IP Infusion will be exhibiting its technologies at the MPLS & Ethernet World Congress, Stand #116 to be held February 9-12 in Paris, France and also on the ACCESS CO., LTD. Stand #CY10 at Mobile World Congress in Barcelona, February 15-18, 2010.

About ACCESS

ACCESS CO., LTD. is a global company providing leading technology, software products and platforms for Web browsing, mobile phones, wireless handhelds, and other networked devices. ACCESS' product portfolio, including its NetFront™ Browser, Garnet™ OS and ACCESS Linux Platform™, provides customers with solutions that enable faster time to market, flexibility and customizability. The company, headquartered in Tokyo, Japan, operates 24 subsidiaries and affiliates within Asia, Europe and the United States. ACCESS is listed on the Tokyo Stock Exchange Mother's Index under the number 4813. For more information about ACCESS, please visit http://www.access-company.com/

About IP Infusion

IP Infusion delivers advanced software solutions that power communications equipment for packet-based Next Generation Networks (NGN). With a unique modular architecture and the industry's broadest suite of communication protocols, IP Infusion enhances product differentiation and market agility for many of the world's leading network equipment vendors. Incorporated in Delaware in October 1999, IP Infusion is headquartered in Sunnyvale, California, and is a wholly owned and independently-operated subsidiary of ACCESS Systems Americas, Inc., a wholly owned U.S. subsidiary of ACCESS CO., LTD., of Tokyo, Japan. For more information about IP Infusion, please visit www.ipinfusion.com.

© 2010 ACCESS CO., LTD. All rights reserved.

ACCESS, the ACCESS logo, NetFront, ACCESS Linux Platform, Garnet are registered trademarks or trademarks of ACCESS CO., LTD. in the United States, Japan and/or other countries. IP Infusion, the IP Infusion logo and ZebOS are either registered trademarks or trademarks of IP Infusion Inc. in the United States and/or other countries. The registered trademark LINUX® is used pursuant to a sublicense from Linux Mark Institute, the exclusive licensee of Linus Torvalds, owner of the mark on a world-wide basis.

All other trademarks, logos and trade names mentioned in the document are the property of their respective owners.

SOURCE IP Infusion